Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 13,928 | 23,411 | 0 | 27,146 | 11,142 |
| Cost of Goods | 4,973 | 5,636 | N/A | 4,880 | 5,141 |
| Gross Profit | 8,955 | 17,775 | N/A | 22,266 | 6,001 |
| Operating Expenses | 42,635 | 13,106 | 0 | 12,725 | 10,201 |
| Operating Income | -32,707 | 5,305 | N/A | 10,421 | -4,059 |
| Interest Expense | 1,927 | 1,927 | 0 | 1,970 | 1,949 |
| Other Income | -1,859 | 721 | 0 | 0 | 111 |
| Pre-tax Income | -36,493 | 4,099 | 0 | 8,451 | -5,897 |
| Net Income Continuous | -36,493 | 4,099 | N/A | 8,451 | -5,897 |
| Net Income | $-36,493 | $4,099 | $N/A | $8,451 | $-5,897 |
| EPS Basic Total Ops | -1.90 | 0.27 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1.90 | 0.27 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.90 | 0.27 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1.90 | 0.27 | N/A | N/A | N/A |
| EBITDA(a) | $-31,465 | $6,716 | $N/A | $11,849 | $-4,059 |